The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

Nature Medicine

Volumn 10, Issue 11, 2004, Pages 1251-1256

  Cheng, Kwai Wa ^a   Lahad, John P ^a   Kuo, Wen Lin ^b   Lapuk, Anna ^b   Yamada, Kyosuke ^b   Auersperg, Nelly ^c   Liu, Jinsong ^a   Smith McCune, Karen ^d   Lu, Karen H ^a   Fishman, David ^e   Gray, Joe W ^b   Mills, Gordon B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN KINASE B; RAB PROTEIN;

AMPLICON; ANOIKIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME 1Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MULTIGENE FAMILY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RAB GTP-BINDING PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 9144271680     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1125     Document Type: Article

References (29)

1. Pinkel, D. et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20, 207-211 (1998).
2. Goldenring, J.R., Shen, K.R., Vaughan, H.D. & Modlin, I.M. Identification of a small GTP-binding protein, Rab25, expressed in the gastrointestinal mucosa, kidney, and lung, J. Biol. Chem. 268, 18419-18422 (1993).
3. Wang, X., Kumar, R., Navarre, J., Casanova, J.E. & Goldenring, J.R. Regulation of vesicle trafficking in Madin-Darby canine kidney cells by Rab11a and Rab25. J. Biol. Chem. 275, 29138-29146 (2000).
4. Shayesteh, L. et al. PI3KCA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21, 99-102(1999).
5. Fukushi, Y., Sato, S., Yokoyama, Y., Kudo, K., Maruyama, H., & Saito, Y. Detection of numerical aberrations in chromosome 17 and c-erbB2 gene amplification in epithelial ovarian cancer using recently established dual color FISH. Eur. J. Gynecol. Oncol. 22, 23-25 (2001).
6. Berchuck, A. & Carney, M. Human ovarian cancer of the surface epithelium. Biochem. Pharmacol. 54, 541-544 (1997).
7. Anand, N. et al. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat. Genet. 31, 301-305 (2002).
8. Cheng, J.Q. et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA 89, 9267-9271 (1992).
9. Anzick, S.L. et al. AIB1, a steroid receptor co-activator amplified in breast and ovarian cancer. Science 277, 965-967 (1997).
10. Suzuki, S. et al. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res. 60, 5382-5385 (2000).
11. Patael-Karasik, Y. et al. Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel. Cancer Genet. Cytogenet. 121, 26-32 (2000).
12. Kiechle, M., Jacobsen, A., Schwarz-Boeger, U., Hedderich, J., Pfisterer, J. & Arnold, N. Comparative genomic hybridization detects genetic inbalance in primary ovarian carcinomas as correlated with grade of differentiation. Cancer 91, 534-540 (2001).
13. Zudaire, I. et al. Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas. Histopathology 40, 547-555 (2002).
14. Lu, Y.J., Hing, S., Williams, R., Pinkerton, R., Shipley, J. & Pritchard-Jones, K. UK Children's Cancer Study Group Wilms' tumor group. Chromosome 1q expression profiling and relapse in Wilms' tumour. Lancet 9330, 385-386 (2002).
15. Lu, K.H. et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin. Cancer Res. 10, 3291-3300 (2004).
16. Schaner, M.E. et al. Gene expression patterns in ovarian carcinomas. Mol. Biol. Cell. 14, 4376-4386 (2003).
17. Sorlie, T. et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 100, 8418-8423 (2003).
18. Calvo, A. et al. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res. 62, 5325-5335 (2002).
19. Mor, O. et al. Molecular analysis of transitional cell carcinoma using cDNA microarray. Oncogene 22, 7702-7710 (2003).
20. Wang, W. et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res. 62, 6278-6288 (2002).
21. Liu, J. et al. A genetically defined model for human ovarian cancer. Cancer Res. 64, 1655-1663 (2004)
22. Milhavet, O., Gary, D.S. & Mattson, M.P. RNA interference in biology and medicine. Pharmacol. Rev. 55, 629-648 (2003).
23. Gross, A., McDonnell, J.M. & Korsmeyer, S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911 (1999).
24. Wei, M. et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730 (2001).
25. Degenhardt, K., Chen, G., Lindsten, T. & White, E. BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell 2, 193-203 (2002).
26. Lu, Y. et al. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 18, 7034-7045 (1999).
27. Mills, G.B. et al. Role of abnormalities of PTEN and the phosphatidylinositol 3′ kinase pathway in breast and ovarian tumorigenesis, prognosis and therapy. Semin. Oncol. 28, S125-S141 (2001).
28. Kennedy, S.G. et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701-713 (1997).
29. Delcroix, J.D., Valletta, J.S., Wu, C., Hunt, S.J., Kowal, A.S. & Mobley, W.C. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron 39, 69-84 (2003).